financetom
Business
financetom
/
Business
/
Budget 2019: Here's a wish list from the banking industry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Budget 2019: Here's a wish list from the banking industry
Jan 28, 2019 6:22 AM

This financial year saw the banking industry grappling with several issues - from mounting bad loans, delays in resolution of large cases under the insolvency and bankruptcy code, liquidity crunch and stress build up in micro, small and medium enterprise (MSME) loans.

Although, there were green-shoots of recovery with credit demand picking up, and incremental addition of bad loans slowing down, the coming financial year will be crucial to restore the health of the banking industry and get it back on its feet after the tough past few years.

For public sector banks (PSBs), that have faced the worst of the bad loan problem due to their larger exposures to infrastructure and steel sectors, capital is the key to revival, and that remains their key demand from the government as it gets set to present the interim budget later this week.

With the vote-on-account due soon, CNBC-TV18 spoke to several banks to gauge what tops their wish list this time around. The central government had announced its plan to infuse Rs 2.11 trillion into 20 state run banks by March 2019, which included banks raising some portion of the capital from the markets themselves through the course of the year.

With PSBs failing to raise the expected Rs 580 billion from markets themselves, the government increased its capital infusion into these banks to Rs 1.06 trillion for the current fiscal. Banks are hopeful that the next tranche of capital support for FY20 will be announced on February 1.

Some bankers also expect government to announce steps that may help the industry tackle the bad loans menace.

Sunil Srivastava, the former head of corporate banking at State Bank of India, said, “Trade Receivables Discounting System (TReDS) should be made compulsory for registration and acceptance by all corporates including the PSUs under ministry of corporate affairs and also include the various authorities of the government (NHAI, Discoms etc.) to ensure continuity of working capital cycles, the absence of which is one of the main reasons for the sickness and NPAs in the country.”

TReDS is an online mechanism for facilitating the financing of trade receivables of MSMEs through multiple financiers.

Banks had earlier made a representation to the union finance ministry on several key issues that they wanted the government to address in the interim budget. A senior banking official who did not wish to be named told CNBC-TV18 that banks have sought GST (Goods & Services Tax) rationalistion on bank accounts, uniform stamp duty across India for documentation along the lines of GST, DICGC (Deposit Insurance and Credit Guarantee Corporation) coverage enhancement from Rs 1 lakh to Rs 5 lakh, and subsidy support to open ATMs in rural areas.

In addition, he added, banks have once again sought a reduction in tenure for tax deposit under 80C and a hike in Tax Deducted at Source (TDS) limit for public from Rs 10,000 to Rs 30,000 annually.

In view of the government’s push for lending to the infrastructure sector, banks have also sough provision to raise tax free bonds to lend to this sector, added another banking official.

“Union budget 2019 will have to do a delicate balancing between prudence and aspirations. I am optimistic about budget being considerate towards needs of banking industry, both in terms of capital allocation and giving tax parity for bank products vis a vis other alternatives. It's time to consolidate gains on inflation by realigning incentives for financial intermediation with welfare of common man being the guiding principles. The benefit of lower inflation is not getting transmitted due to high cost of deposits. Some initiatives in this direction will be beneficial to the economy,” said Rajkiran Rai, the managing director and chief executive officer at Union Bank of India, told CNBC-TV18.

First Published:Jan 28, 2019 3:22 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Owens Corning to Build Shingle Manufacturing Plant in Southeastern US
Owens Corning to Build Shingle Manufacturing Plant in Southeastern US
Feb 11, 2025
10:15 AM EST, 02/11/2025 (MT Newswires) -- Owens Corning ( OC ) said Tuesday it plans to build a shingle manufacturing plant in the southeastern United States to expand its roofing production network. The facility will have a four-wide laminator with an annual capacity of roughly six million squares, with production expected to begin in 2027, the company said. Owens...
What's Going On With Carvana Stock Today?
What's Going On With Carvana Stock Today?
Feb 11, 2025
Carvana Co. ( CVNA ) announced that it will integrate its Inspection and Reconditioning Center capabilities into the existing ADESA Indianapolis wholesale auction site. The new “Megasite” will combine Carvana’s digital and in-lane auction operations with reconditioning services, boosting the company’s production capacity and offering serviceS to retail and wholesale customers in the Indianapolis area. The transition is expected to...
Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025
Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025
Feb 11, 2025
10:19 AM EST, 02/11/2025 (MT Newswires) -- Voyager Therapeutics' ( VYGR ) shares dropped nearly 13% in recent Tuesday trading after the company said it no longer expects to file an investigational new drug application for VY9323 in mid-2025. The biotechnology company reported an obstacle in its superoxide dismutase 1 amyotrophic lateral sclerosism, or SOD1 ALS, gene therapy program, as...
Lineage Cell Therapeutics Begins Stem Cell Therapy Trial for Spinal Cord Injury
Lineage Cell Therapeutics Begins Stem Cell Therapy Trial for Spinal Cord Injury
Feb 11, 2025
10:20 AM EST, 02/11/2025 (MT Newswires) -- Lineage Cell Therapeutics ( LCTX ) said Tuesday it started a clinical study evaluating OPC1, an investigational allogeneic stem cell-derived transplant for spinal cord injury. OPC1 is designed to replace or support spinal cord cells that are absent or dysfunctional due to traumatic injury, aiming to restore or enhance functional activity in affected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved